Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan M Glanzman

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Developmental Medicine and Child Neurology|April 30, 2026
Performance outcomes of the PEDI-CAT for assessing functional ability in the population with leukodystrophyStacy V Cusack, Allan M Glanzman, Francesco Gavazzi, et al.
Neurology. Clinical Practice|November 22, 2019
A multidisciplinary approach to dosing nusinersen for spinal muscular atrophyCarla D Zingariello, John Brandsema, Elizabeth Drum, et al.
Muscle & Nerve|January 6, 2023
Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysisReza Sadjadi, Kristina Kelly, Allan M Glanzman, et al.
Journal of Neuromuscular Diseases|February 22, 2020
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1Sally Dunaway Young, Jacqueline Montes, Rachel Salazar, et al.
Muscle & Nerve|May 18, 2013
The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter studyCraig M McDonald, Erik K Henricson, R Ted Abresch, et al.
Molecular Genetics and Metabolism|November 20, 2012
Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidaseTyler Mark Pierson, Paola A Torres, Bei-Jin Zeng, et al.
Muscle & Nerve|May 16, 2013
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter studyCraig M McDonald, Erik K Henricson, R Ted Abresch, et al.
Archives of Physical Medicine and Rehabilitation|June 29, 2014
Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathyCarole Vuillerot, Pascal Rippert, Virginie Kinet, et al.
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Physical therapy services received by individuals with spinal muscular atrophy (SMA)Sally Dunaway, Jacqueline Montes, Michael P McDermott, et al.
Pediatric Neurology|October 8, 2021
Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With LeukodystrophyFrancesco Gavazzi, Laura Adang, Amy Waldman, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Developmental Medicine and Child Neurology|April 30, 2026
Performance outcomes of the PEDI-CAT for assessing functional ability in the population with leukodystrophyStacy V Cusack, Allan M Glanzman, Francesco Gavazzi, et al.
Neurology. Clinical Practice|November 22, 2019
A multidisciplinary approach to dosing nusinersen for spinal muscular atrophyCarla D Zingariello, John Brandsema, Elizabeth Drum, et al.
Muscle & Nerve|January 6, 2023
Psychometric evaluation of modified spinal muscular atrophy functional rating scale (SMAFRS) in adult patients using Rasch analysisReza Sadjadi, Kristina Kelly, Allan M Glanzman, et al.
Journal of Neuromuscular Diseases|February 22, 2020
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1Sally Dunaway Young, Jacqueline Montes, Rachel Salazar, et al.
Muscle & Nerve|May 18, 2013
The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter studyCraig M McDonald, Erik K Henricson, R Ted Abresch, et al.
Molecular Genetics and Metabolism|November 20, 2012
Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidaseTyler Mark Pierson, Paola A Torres, Bei-Jin Zeng, et al.
Muscle & Nerve|May 16, 2013
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter studyCraig M McDonald, Erik K Henricson, R Ted Abresch, et al.
Archives of Physical Medicine and Rehabilitation|June 29, 2014
Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathyCarole Vuillerot, Pascal Rippert, Virginie Kinet, et al.
Journal of Pediatric Rehabilitation Medicine|March 12, 2016
Physical therapy services received by individuals with spinal muscular atrophy (SMA)Sally Dunaway, Jacqueline Montes, Michael P McDermott, et al.
Pediatric Neurology|October 8, 2021
Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With LeukodystrophyFrancesco Gavazzi, Laura Adang, Amy Waldman, et al.
Pageof 8